Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Thrombosis and Haemostasis

• Publication date

  2011-05-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1160/TH10-10-0674PMID 21614409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey

  2012cited by this paper
• Quality of Wafarin Control Affects the Incidence of Stroke in Elderly Patients with Atrial Fibrillation

  2010cited by this paper
• Oral Anticoagulation in Nonvalvular Atrial Fibrillation in Clinical Practice: Impact of CHADS2 Score on Outcome

  2010cited by this paper
• Quality of warfarin control affects the incidence of stroke in elderly patients with atrial fibrillation.

  2010cited by this paper
• A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

  2010cited by this paper
• The Effect and Safety of the Antithrombotic Therapies in Patients with Atrial Fibrillation and CHADS2 Score 1

  2010cited by this paper
• Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1

  2010cited by this paper
• Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.

  2010cited by this paper
• Relationship between CHADS2 score and ischemic stroke during rhythm control therapy for paroxysmal atrial fibrillation.

  2010cited by this paper
• Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States

  2009cited by this paper
• The quality of anticoagulation on functional outcome and mortality for TIA/stroke in atrial fibrillation patients.

  2009cited by this paper
• Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.

  2009cited by this paper
• Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients

  2009cited by this paper
• Ten-year experience with acenocoumarol treatment in an ambulatory cohort of Spanish patients

  2009cited by this paper
• How Well Does the Target INR Level Maintain in Warfarin-Treated Patients with Non-ValvularAtrial Fibrillation?

  2009cited by this paper
• Stroke risk in atrial fibrillation patients on warfarin

  2009cited by this paper
• Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.

  2009cited by this paper
• Anticoagulation for valvular heart disease in community-based practice

  2009cited by this paper
• Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation.

  2009cited by this paper
• Atrial fibrillation and stroke risk prevention in real-life clinical practice

  2009cited by this paper
• Randomized controlled trial of supervised patient self‐testing of warfarin therapy using an internet‐based expert system

  2009cited by this paper
• [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].

  2008cited by this paper
• Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature.

  2008cited by this paper
• Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation

  2008cited by this paper
• Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians

  2008cited by this paper
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range

  2008cited by this paper
• Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation.

  2008cited by this paper
• Warfarin for atrial fibrillation in community‐based practise

  2008cited by this paper
• Epidemiology and outcomes in patients with atrial fibrillation in the United States.

  2008cited by this paper
• Predicción de eventos embólicos en pacientes con fibrilación auricular no valvular: evaluación del score CHADS 2 en una población mediterránea

  2008cited by this paper
• Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care

  2008cited by this paper
• Application of a Decision Support Tool for Anticoagulation in Patients with Non-valvular Atrial Fibrillation

  2008cited by this paper
• Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.

  2007cited by this paper
• The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study.

  2007cited by this paper
• Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation

  2007influential reference
• Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

  2007cited by this paper
• Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.

  2007cited by this paper
• [Atrial fibrillation: prevalence, risk factors and mortality in a large French population with 15 years of follow-up].

  2007cited by this paper
• 'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation.

  2007cited by this paper
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation

  2007cited by this paper
• The risk of bleeding with warfarin: A systematic review and performance analysis of clinical prediction rules

  2007cited by this paper
• Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review.

  2007influential reference
• Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

  2007cited by this paper
• Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.

  2007cited by this paper
• Fibrillation atriale: prévalence, facteurs de risque et mortalité dans une vaste population française suivie 15 ans.

  2007cited by this paper
• Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score.

  2007cited by this paper
• A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).

  2007cited by this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC

  2006cited by this paper
• Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

  2006cited by this paper
• Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, P

  2006cited by this paper
• Guidelines for the Management of Patients With Atrial Fibrillation

  2006cited by this paper
• Age and the Risk of Warfarin‐Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study

  2006cited by this paper
• The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study.

  2006cited by this paper
• Quality of oral anticoagulation in patients with atrial fibrillation: A cross-sectional study in general practice

  2006cited by this paper
• Effect of study setting on anticoagulation control: a systematic review and metaregression.

  2006cited by this paper
• Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system*

  2005cited by this paper
• Risks of oral anticoagulant therapy with increasing age.

  2005cited by this paper
• Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin

  2005cited by this paper
• Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population

  2005cited by this paper
• Culprit Factors for the Failure of Well-Conducted Warfarin Therapy to Prevent Ischemic Events in Patients With Atrial Fibrillation: The Role of Homocysteine

  2005cited by this paper
• Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study

  2005cited by this paper
• Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.

  2005cited by this paper
• Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care.

  2005cited by this paper
• Management of oral anticoagulant therapy in the real practice of an anticoagulation clinic: focus on atrial fibrillation

  2005cited by this paper
• Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin

  2004cited by this paper
• The use of warfarin in veterans with atrial fibrillation

  2004cited by this paper
• Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.

  2004cited by this paper
• Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients

  2004cited by this paper
• Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study).

  2004cited by this paper
• Recurrent vascular events in patients with ischemic stroke/TIA and atrial fibrillation in relation to secondary prevention at hospital discharge

  2004cited by this paper
• Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).

  2004cited by this paper
• Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital

  2004cited by this paper
• Morbidity and mortality in 229 elderly patients with nonrheumatic atrial fibrillation. A five-year follow-up.

  2003cited by this paper
• Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.

  2003cited by this paper
• Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.

  2003cited by this paper
• Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

  2003cited by this paper
• Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications.

  2001cited by this paper
• Atrial Fibrillation and Antithrombotic Treatment in Italian Hospitalized Patients: A Prospective, Observational Study

  2001cited by this paper
• Non-valvular atrial fibrillation and stroke prevention. National Blood Pressure Advisory Committee of the National Heart Foundation.

  2001cited by this paper
• Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Risk of Bleeding

  2001cited by this paper
• Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

  2001cited by this paper
• Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice

  2001cited by this paper
• Non‐valvular atrial fibrillation and stroke prevention

  2001cited by this paper
• Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness

  2000cited by this paper
• Secondary Stroke Prevention in Atrial Fibrillation: Lessons From Clinical Practice

  2000cited by this paper
• Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.

  1999cited by this paper
• Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

  1999cited by this paper
• Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?

  1994cited by this paper
• A FIVE-YEAR FOLLOW-UP

  1982cited by this paper
• Secondary

  1976cited by this paper

• Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation

  2024influential citation
• Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants

  2022cites this paper
• Clinical Outcomes of Very Elderly Patients With Atrial Fibrillation Receiving On‐label Doses of Apixaban: J‐ELD AF Registry Subanalysis

  2021cites this paper
• Risk of left atrial appendage thrombus in older patients with atrial fibrillation

  2021cites this paper
• ASSOCIATION OF INR QUALITY WITH COMPLICATIONS AMONG PATIENTS ON WARFARIN THERAPY IN HOSPITAL SULTAN ISMAIL PETRA, KELANTAN STATE

  2020influential citation
• Impact of prescription patterns of antithrombotic treatment on atrial fibrillation-related ischemic stroke

  2020cites this paper
• Biomarkers Associated with Bleeding Risk in the Setting of Atrial Fibrillation.

  2019cites this paper
• Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin

  2017cites this paper
• Use of HAS-BLED Score in an Anticoagulation Outpatient Clinic of a Tertiary Hospital

  2017cites this paper
• Stroke and the heart : a focus on atrial fibrillation and heart failure

  2017cites this paper
• Latin American Clinical Epidemiology Network Series - Paper 2: Apixaban was cost-effective vs. acenocoumarol in patients with nonvalvular atrial fibrillation with moderate to severe risk of embolism in Chile.

  2017cites this paper
• New Cholesterol Targets of SBC Guidelines on Dyslipidemia

  2017cites this paper
• Patients ’ and health professionals ’ views and experiences of atrial fibrillation and oral-anticoagulant therapy : a meta-synthesis

  2016cites this paper
• Caracterización de la fibrilación auricular en el Servicio de Medicina Interna del Hospital Nacional San Rafael (El Salvador)

  2016cites this paper
• Stroke Prevention in Atrial Fibrillation: Focus on Latin America

  2016cites this paper
• Improving medical decision making: Stroke prevention in atrial fibrillation

  2016cites this paper
• Sécurité et tolérance des anticoagulants oraux directs dans une population de fibrillation auriculaire : étude prospective monocentrique

  2016cites this paper
• Contemporary measures to reduce the risk of embolic events in patients with atrial fibrillation.

  2015cites this paper
• Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study.

  2015cites this paper
• Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation

  2015cites this paper
• Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice

  2015cites this paper
• Untreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment options.

  2015cites this paper
• Catch Atrial Fibrillation, Prevent Stroke : Detection of atrial fibrillation and other arrhythmias with short intermittent ECG

  2015cites this paper
• Bilan rétrospectif sur un an des hospitalisations en neurologie pour accident vasculaire cérébral : apport de la pharmacovigilance

  2015cites this paper
• The Potential Role of Edoxaban in Stroke Prevention Guidelines.

  2014cites this paper
• [Efficacy and safety of apixaban compared with warfarin regarding time within the therapeutic range].

  2014cites this paper
• Acetylsalicylic acid for stroke prevention in atrial fibrillation: a conspiracy that needs to end?

  2014cites this paper
• Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants.

  2014cites this paper
• Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure

  2014cites this paper
• Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: Cross-sectional population database study

  2014cites this paper
• Utilisation des bases médico-administratives dans la surveillance des effets indésirables : patients porteurs d’une fibrillation auriculaire et dabigatran

  2014influential citation
• Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis.

  2014cites this paper
• Preadmission oral anticoagulant therapy and clinical outcome in patients hospitalised with acute stroke and atrial fibrillation.

  2014cites this paper
• Review of Economics and Cost-Effectiveness Analyses of Anticoagulant Therapy for Stroke Prevention in Atrial Fibrillation in the US

  2013cites this paper
• [Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: Hemorrhagic risk and guidelines recommendations].

  2013cites this paper
• General mechanisms of coagulation and targets of anticoagulants (Section I)

  2013cites this paper
• Do open label blinded outcome studies of novel anticoagulants versus warfarin have equivalent validity to those carried out under double-blind conditions?

  2013cites this paper
• New Avenues for Anticoagulation in Atrial Fibrillation

  2013cites this paper
• Stratificazione del rischio tromboembolico ed emorragico nei pazienti con fibrillazione atriale. Parte I: il rischio tromboembolico Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk

  2013cites this paper
• Frequency and Risk Factors for Under- and Over-Treatment in Stroke Prevention for Patients with Non-Valvular Atrial Fibrillation in General Practice

  2013cites this paper
• Stratificazione del rischio ischemico ed emorragico nei pazienti con fibrillazione atriale. Parte II: il rischio emorragico e le raccomandazioni delle linee guida Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: hemorrhagic risk and guidelines recomme

  2013cites this paper
• Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice

  2013cites this paper
• New Avenues for Anticoagulation in Atrial

  2013cites this paper
• Improving stroke prevention in patients with atrial fibrillation

  2013cites this paper
• How early is early enough to prevent stroke in atrial fibrillation?

  2012cites this paper
• Treatment pathways for atrial fibrillation: simplifying the approach to thromboprophylaxis

  2012cites this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

  2012cites this paper
• What is the most effective and safest delivery of thromboprophylaxis in atrial fibrillation?

  2012cites this paper
• A new algorithm to predict warfarin dose from polymorphisms of CYP4F2, CYP2C9 and VKORC1 and clinical variables: Derivation in Han Chinese patients with non valvular atrial fibrillation

  2012cites this paper
• Patients' and health professionals' views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis.

  2012cites this paper
• Oral antithrombotic therapy and gastrointestinal bleeding: the good, the bad and the ugly

  2012cites this paper
• Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: What’s next?

  2012cites this paper
• The even closer link between the thyroid and haemostasis

  2012cites this paper
• Prognosis in Patients with Atrial Fibrillation and CHA2DS2‐VASc Score = 0 in a Community‐Based Cohort Study

  2012cites this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

  2012cites this paper
• Bleeding risk assessment and management in atrial fibrillation patients.

  2012cites this paper
• Prescribing anticoagulation medication for the elderly

  2012cites this paper
• Looking through the PRISM: New Insights for Young Patients with Atrial Fibrillation and Stroke

  2011cites this paper
• Bleeding risk assessment and management in atrial fibrillation patients

  2011cites this paper